Banks - Regional
Compare Stocks
3 / 10Stock Comparison
CHYM vs SOFI vs DAVE
Revenue, margins, valuation, and 5-year total return — side by side.
Financial - Credit Services
Software - Application
CHYM vs SOFI vs DAVE — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||
|---|---|---|---|
| Industry | Banks - Regional | Financial - Credit Services | Software - Application |
| Market Cap | $7.61B | $20.40B | $3.35B |
| Revenue (TTM) | $2.19B | $4.77B | $552M |
| Net Income (TTM) | $-969M | $481M | $225M |
| Gross Margin | 85.9% | 75.1% | 81.5% |
| Operating Margin | -47.6% | 11.0% | 4.9% |
| Forward P/E | 112.9x | 26.5x | 19.1x |
| Total Debt | $135M | $1.82B | $75M |
| Cash & Equiv. | $466M | $4.93B | $81M |
CHYM vs SOFI vs DAVE — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 25 | May 26 | Return |
|---|---|---|---|
| Chime Financial, In… (CHYM) | 100 | 55.1 | -44.9% |
| SoFi Technologies, … (SOFI) | 100 | 87.9 | -12.1% |
| Dave Inc. (DAVE) | 100 | 92.9 | -7.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CHYM vs SOFI vs DAVE
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CHYM is the clearest fit if your priority is income & stability and sleep-well-at-night.
- beta 2.50
- Lower volatility, beta 2.50, Low D/E 9.6%, current ratio 4.53x
- Beta 2.50, current ratio 4.53x
SOFI is the clearest fit if your priority is long-term compounding.
- 52.7% 10Y total return vs DAVE's -20.5%
DAVE carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth 47.5%, EPS growth 222.9%, 3Y rev CAGR 35.7%
- 47.5% revenue growth vs SOFI's 28.8%
- Lower P/E (19.1x vs 112.9x)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 47.5% revenue growth vs SOFI's 28.8% | |
| Value | Lower P/E (19.1x vs 112.9x) | |
| Quality / Margins | 40.8% margin vs CHYM's -46.2% | |
| Stability / Safety | Beta 2.50 vs DAVE's 2.69, lower leverage | |
| Dividends | Tie | None of these 3 stocks pay a meaningful dividend |
| Momentum (1Y) | +131.2% vs CHYM's -48.8% | |
| Efficiency (ROA) | 49.6% ROA vs CHYM's -49.8%, ROIC 11.1% vs -60.2% |
CHYM vs SOFI vs DAVE — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CHYM vs SOFI vs DAVE — Financial Metrics
Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
DAVE leads in 3 of 6 categories
CHYM leads 0 • SOFI leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
DAVE leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
SOFI is the larger business by revenue, generating $4.8B annually — 8.6x DAVE's $552M. DAVE is the more profitable business, keeping 40.8% of every revenue dollar as net income compared to CHYM's -46.2%.
| Metric | |||
|---|---|---|---|
| RevenueTrailing 12 months | $2.2B | $4.8B | $552M |
| EBITDAEarnings before interest/tax | -$976M | $760M | $33M |
| Net IncomeAfter-tax profit | -$969M | $481M | $225M |
| Free Cash FlowCash after capex | $144M | -$2.6B | $327M |
| Gross MarginGross profit ÷ Revenue | +85.9% | +75.1% | +81.5% |
| Operating MarginEBIT ÷ Revenue | -47.6% | +11.0% | +4.9% |
| Net MarginNet income ÷ Revenue | -46.2% | +10.1% | +40.8% |
| FCF MarginFCF ÷ Revenue | +1.5% | -83.5% | +59.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | +36.7% |
| EPS Growth (YoY)Latest quarter vs prior year | -35.0% | -56.7% | +104.1% |
Valuation Metrics
Evenly matched — CHYM and SOFI and DAVE each lead in 2 of 6 comparable metrics.
Valuation Metrics
At 18.4x trailing earnings, DAVE trades at a 55% valuation discount to SOFI's 41.0x P/E. On an enterprise value basis, SOFI's 22.8x EV/EBITDA is more attractive than DAVE's 69.5x.
| Metric | |||
|---|---|---|---|
| Market CapShares × price | $7.6B | $20.4B | $3.4B |
| Enterprise ValueMkt cap + debt − cash | $7.3B | $17.3B | $3.3B |
| Trailing P/EPrice ÷ TTM EPS | -7.15x | 41.03x | 18.42x |
| Forward P/EPrice ÷ next-FY EPS est. | 112.89x | 26.45x | 19.07x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — |
| EV / EBITDAEnterprise value multiple | — | 22.75x | 69.52x |
| Price / SalesMarket cap ÷ Revenue | 3.48x | 4.28x | 6.55x |
| Price / BookPrice ÷ Book value/share | 32.04x | 1.91x | 10.23x |
| Price / FCFMarket cap ÷ FCF | 231.45x | — | 11.57x |
Profitability & Efficiency
DAVE leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
DAVE delivers a 84.5% return on equity — every $100 of shareholder capital generates $85 in annual profit, vs $-68 for CHYM. CHYM carries lower financial leverage with a 0.10x debt-to-equity ratio, signaling a more conservative balance sheet compared to DAVE's 0.21x. On the Piotroski fundamental quality scale (0–9), DAVE scores 5/9 vs SOFI's 3/9, reflecting solid financial health.
| Metric | |||
|---|---|---|---|
| ROE (TTM)Return on equity | -67.9% | +5.9% | +84.5% |
| ROA (TTM)Return on assets | -49.8% | +1.1% | +49.6% |
| ROICReturn on invested capital | -60.2% | +3.6% | +11.1% |
| ROCEReturn on capital employed | -78.1% | +1.2% | +12.9% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 3 | 5 |
| Debt / EquityFinancial leverage | 0.10x | 0.17x | 0.21x |
| Net DebtTotal debt minus cash | -$332M | -$3.1B | -$5M |
| Cash & Equiv.Liquid assets | $466M | $4.9B | $81M |
| Total DebtShort + long-term debt | $135M | $1.8B | $75M |
| Interest CoverageEBIT ÷ Interest expense | — | 0.45x | 22.86x |
Total Returns (Dividends Reinvested)
DAVE leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in SOFI five years ago would be worth $9,691 today (with dividends reinvested), compared to $5,123 for CHYM. Over the past 12 months, DAVE leads with a +131.2% total return vs CHYM's -48.8%. The 3-year compound annual growth rate (CAGR) favors DAVE at 2.6% vs CHYM's -20.0% — a key indicator of consistent wealth creation.
| Metric | |||
|---|---|---|---|
| YTD ReturnYear-to-date | -28.0% | -41.7% | +13.6% |
| 1-Year ReturnPast 12 months | -48.8% | +23.0% | +131.2% |
| 3-Year ReturnCumulative with dividends | -48.8% | +192.5% | +4740.2% |
| 5-Year ReturnCumulative with dividends | -48.8% | -3.1% | -20.2% |
| 10-Year ReturnCumulative with dividends | -48.8% | +52.7% | -20.5% |
| CAGR (3Y)Annualised 3-year return | -20.0% | +43.0% | +2.6% |
Risk & Volatility
Evenly matched — CHYM and DAVE each lead in 1 of 2 comparable metrics.
Risk & Volatility
CHYM is the less volatile stock with a 2.50 beta — it tends to amplify market swings less than DAVE's 2.69 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. DAVE currently trades 86.6% from its 52-week high vs CHYM's 42.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||
|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.50x | 2.54x | 2.69x |
| 52-Week HighHighest price in past year | $44.94 | $32.73 | $287.69 |
| 52-Week LowLowest price in past year | $16.17 | $12.56 | $105.83 |
| % of 52W HighCurrent price vs 52-week peak | +42.3% | +48.9% | +86.6% |
| RSI (14)Momentum oscillator 0–100 | 50.6 | 41.9 | 51.5 |
| Avg Volume (50D)Average daily shares traded | 4.7M | 65.8M | 607K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: CHYM as "Buy", SOFI as "Hold", DAVE as "Buy". Consensus price targets imply 39.4% upside for CHYM (target: $27) vs 24.1% for DAVE (target: $309).
| Metric | |||
|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $26.50 | $20.89 | $309.25 |
| # AnalystsCovering analysts | 8 | 27 | 11 |
| Dividend YieldAnnual dividend ÷ price | — | — | — |
| Dividend StreakConsecutive years of raises | — | 0 | — |
| Dividend / ShareAnnual DPS | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +1.0% | +0.3% | +1.3% |
DAVE leads in 3 of 6 categories — strongest in Income & Cash Flow and Profitability & Efficiency. 2 categories are tied.
CHYM vs SOFI vs DAVE: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CHYM or SOFI or DAVE a better buy right now?
For growth investors, Dave Inc.
(DAVE) is the stronger pick with 47. 5% revenue growth year-over-year, versus 28. 8% for SoFi Technologies, Inc. (SOFI). Dave Inc. (DAVE) offers the better valuation at 18. 4x trailing P/E (19. 1x forward), making it the more compelling value choice. Analysts rate Chime Financial, Inc. Class A Common Stock (CHYM) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CHYM or SOFI or DAVE?
On trailing P/E, Dave Inc.
(DAVE) is the cheapest at 18. 4x versus SoFi Technologies, Inc. at 41. 0x. On forward P/E, Dave Inc. is actually cheaper at 19. 1x.
03Which is the better long-term investment — CHYM or SOFI or DAVE?
Over the past 5 years, SoFi Technologies, Inc.
(SOFI) delivered a total return of -3. 1%, compared to -48. 8% for Chime Financial, Inc. Class A Common Stock (CHYM). Over 10 years, the gap is even starker: SOFI returned +52. 7% versus CHYM's -48. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CHYM or SOFI or DAVE?
By beta (market sensitivity over 5 years), Chime Financial, Inc.
Class A Common Stock (CHYM) is the lower-risk stock at 2. 50β versus Dave Inc. 's 2. 69β — meaning DAVE is approximately 7% more volatile than CHYM relative to the S&P 500. On balance sheet safety, Chime Financial, Inc. Class A Common Stock (CHYM) carries a lower debt/equity ratio of 10% versus 21% for Dave Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CHYM or SOFI or DAVE?
By revenue growth (latest reported year), Dave Inc.
(DAVE) is pulling ahead at 47. 5% versus 28. 8% for SoFi Technologies, Inc. (SOFI). On earnings-per-share growth, the picture is similar: Dave Inc. grew EPS 222. 9% year-over-year, compared to -37. 2% for Chime Financial, Inc. Class A Common Stock. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CHYM or SOFI or DAVE?
Dave Inc.
(DAVE) is the more profitable company, earning 38. 3% net margin versus -46. 2% for Chime Financial, Inc. Class A Common Stock — meaning it keeps 38. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SOFI leads at 11. 0% versus -47. 6% for CHYM. At the gross margin level — before operating expenses — CHYM leads at 85. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CHYM or SOFI or DAVE more undervalued right now?
On forward earnings alone, Dave Inc.
(DAVE) trades at 19. 1x forward P/E versus 112. 9x for Chime Financial, Inc. Class A Common Stock — 93. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CHYM: 39. 4% to $26. 50.
08Which pays a better dividend — CHYM or SOFI or DAVE?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is CHYM or SOFI or DAVE better for a retirement portfolio?
For long-horizon retirement investors, SoFi Technologies, Inc.
(SOFI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding. Chime Financial, Inc. Class A Common Stock (CHYM) carries a higher beta of 2. 50 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SOFI: +52. 7%, CHYM: -48. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CHYM and SOFI and DAVE?
These companies operate in different sectors (CHYM (Financial Services) and SOFI (Financial Services) and DAVE (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.